- In January 2023, Agilent Technologies partnered with Akoya Biosciences to develop multiplex-immunohistochemistry and immunofluorescence workflows. By combining Agilent’s Dako Omnis autostainer and Akoya’s PhenoImager HT imaging platform, both companies aim to deliver an end-to-end commercial solution for tissue biomarker analysis in precision oncology
- In April 2025, Akoya Biosciences teamed up with Enable Medicine to launch the world’s largest commercially available single-cell spatial proteomics atlas, profiling over 100 million cells across 8,500+ samples and 15 cancer types — a significant milestone in spatial biology
- In January 2025, Genethon and Eukarÿs announced a strategic partnership to reduce biomanufacturing costs for gene therapies. The collaboration leverages Eukarÿs’ proprietary C3P3 mRNA expression platform within mammalian cells
- In April 2025, AGC Biologics launched a dedicated Cell & Gene Technologies Division across global CDMO sites. This expands manufacturing capacity for viral vectors and cell therapies, supporting accelerated development pipelines
